Collaboration powers secure international data sharing through the HiFi Solves Global Consortium MENLO PARK, Calif. — PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced a collaboration with DNAstack to power the world’s first global federated dataset of HiFi whole genome sequencing data. Through the HiFi Solves Global Consortium, the collaboration […]

TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow Data presented at AGBT demonstrates TruPath Genome’s accuracy in detecting rare genetic disease Broad Clinical Labs is among first to adopt product, which was previously known as “constellation mapped read technology” SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced the launch of TruPath™ […]

SAN JOSE, Calif. and MARCO ISLAND, Fla. — Complete Genomics, a U.S.-based, innovator in genomic sequencing platforms and solutions, today announced it is commencing shipments of DNBSEQ-T7+ high-throughput sequencing platform at the 2026 Advances in Genome Biology and Technology (AGBT) conference. The launch reinforces the company’s continued investment in scalable, cost-efficient sequencing solutions designed to meet the growing demands […]

CAMBRIDGE, England & SAN DIEGO — biomodal, an omics-based life sciences technology and analytics company, today announced at the AGBT 2026 General Meeting that biomodal’s duet multiomic solutions are compatible with Element Biosciences AVITI24™ 5D multiomics and AVITI™ sequencing instruments. Validated at the University of Minnesota (UMN) Genomics Center, this integration delivers enhanced sensitivity for applications including […]

New innovations designed to simplify NGS workflows Enhances critical variant identification through improved technologies Roadmap advances provide flexibility across targeted and whole genome applications BOULDER, Colo. — For more than three decades, Integrated DNA Technologies (IDT) has helped power the genomics revolution, enabling scientists to decode biology with growing precision and speed. Today, as cancer research […]

New commercial kit brings Nature Communications-validated methylation analysis chemistry to researchers working with low-input and cfDNA samples CAMBRIDGE, Mass. — Ellis Bio, a developer of next-generation epigenomics technologies, today announced the official commercial launch of its SuperMethyl™ Max Bisulfite Conversion Kit, a new and gentle methyl conversion solution designed for highly sensitive methylation detection from low-input and fragile […]

Twice the output, half the runtime, and half the footprint of the UG 100® with greater flexibility and improved genomic coverage Introducing two new high-throughput instrument configurations accessible for as low as $850,000 Next-gen amplification eliminates the need for a dedicated ePCR instrument and greatly improves coverage in clinically relevant regions of the genome, while maintaining Ultima’s […]

SAN JOSE, Calif. and BASEL, Switzerland — Complete Genomics, a U.S.-based innovator in genomic sequencing technology, today confirmed that it has entered into a definitive agreement, subject to customary closing conditions and approval by MGI shareholders, under which it will be acquired by Swiss Rockets AG, a Switzerland-based life sciences group. The transaction will enable the scaling of the […]

40% increase in output to 35 billion reads, up to Q70 quality scores,improved turnaround time, and staggered starts are among the updates to be rolled out on all NovaSeq X systems, advancing precision medicine and delivering compounded value for NovaSeq X customers SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today unveiled an 18-month roadmap of innovations […]

Basel, Switzerland – Swiss Rockets AG announces that its CoolMPS 600 mid-throughput sequencer with advanced chemistry and novel MPS/NGS read length will become available in Q2 2026. Enabled by its exclusive license of CoolMPS technology, Swiss Rockets AG is developing its first sequencer, CoolMPS 600, through contract R&D with Complete Genomics since August 2025. The […]